Incidence, Phenotypic Features and Molecular Genetics of Kallmann Syndrome in Finland
Open Access
- 17 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 6 (1), 41
- https://doi.org/10.1186/1750-1172-6-41
Abstract
Kallmann syndrome (KS), comprised of congenital hypogonadotropic hypogonadism (HH) and anosmia, is a clinically and genetically heterogeneous disorder. Its exact incidence is currently unknown, and a mutation in one of the identified KS genes has only been found in ~30% of the patients. Herein, we investigated epidemiological, clinical, and genetic features of KS in Finland. The minimal incidence estimate of KS in Finland was 1:48 000, with clear difference between males (1:30 000) and females (1:125 000) (p = 0.02). The reproductive phenotype of 30 probands (25 men; 5 women) ranged from severe HH to partial puberty. Comprehensive mutation analysis of all 7 known KS genes (KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, and WDR11) in these 30 well-phenotyped probands revealed mutations in KAL1 (3 men) and FGFR1 (all 5 women vs. 4/25 men), but not in other genes. Our results suggest that Finnish KS men harbor mutations in gene(s) yet-to-be discovered with sex-dependent penetrance of the disease phenotype. In addition, some KS patients without CHD7 mutations display CHARGE-syndrome associated phenotypic features (e.g. ear or eye anomalies), possibly implying that, in addition to CHD7, there may be other genes associated with phenotypes ranging from KS to CHARGE.Keywords
This publication has 52 references indexed in Scilit:
- WDR11, a WD Protein that Interacts with Transcription Factor EMX1, Is Mutated in Idiopathic Hypogonadotropic Hypogonadism and Kallmann SyndromeAmerican Journal of Human Genetics, 2010
- Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditionsJCI Insight, 2010
- Oligogenic basis of isolated gonadotropin-releasing hormone deficiencyProceedings of the National Academy of Sciences of the United States of America, 2010
- The genetic and molecular basis of idiopathic hypogonadotropic hypogonadismNature Reviews Endocrinology, 2009
- CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndromeClinical Genetics, 2008
- Kallmann syndromeEuropean Journal of Human Genetics, 2008
- Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann SyndromeAmerican Journal of Human Genetics, 2008
- Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences of the United States of America, 2007
- Impaired FGF signaling contributes to cleft lip and palateProceedings of the National Academy of Sciences of the United States of America, 2007
- Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences of the United States of America, 2006